Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier Detection (PHINDER)

Status: Recruiting
Location: See all (42) locations...
Intervention Type: Procedure
Study Type: Observational
SUMMARY

Study GMS-PH-001 is a multicenter, open-label, non-randomized study to prospectively evaluate screening strategies of pulmonary hypertension (PH) in patients with interstitial lung disease (ILD).

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Patient gives voluntary written informed consent to participate in the study and are capable of reading and understanding questionnaires or forms in English or Spanish.

• Patients with a diagnosis of ILD based on computed tomography imaging, including:

‣ Idiopathic interstitial pneumonia, including idiopathic pulmonary fibrosis

⁃ Connective tissue disease-associated ILD with forced vital capacity (FVC) \<70%

⁃ Hypersensitivity pneumonitis

⁃ Scleroderma-related ILD

⁃ Autoimmune ILD

⁃ Nonspecific interstitial pneumonia

⁃ Occupational lung disease

⁃ Combined pulmonary fibrosis and emphysema with mild emphysema on lung imaging as determined by the Investigator

• Patients must have at least 2 signs or symptoms suggestive of PH, as specified by the study protocol.

Locations
United States
Arizona
Pulmonary Associates
RECRUITING
Phoenix
Connecticut
Hartford Hospital
RECRUITING
Hartford
Florida
Lakeland Regional Health
RECRUITING
Lakeland
NCH Healthcare System
RECRUITING
Naples
University of South Florida Health
RECRUITING
Tampa
Cleveland Clinic Florida
RECRUITING
Weston
Georgia
Emory University Hospital
RECRUITING
Atlanta
Piedmont Healthcare
RECRUITING
Austell
Illinois
Loyola University Chicago
RECRUITING
Chicago
Northwestern University
RECRUITING
Chicago
NorthShore University Health System
RECRUITING
Glenview
Kentucky
University of Kentucky Medical Center
RECRUITING
Lexington
Louisiana
LSU Health Sciences Center New Orleans
RECRUITING
New Orleans
Michigan
University of Michigan Int Med Pulmonary and Critical Care
RECRUITING
Ann Arbor
Mclaren Greater Lansing
RECRUITING
Okemos
Missouri
Blessing Health Hannibal
RECRUITING
Hannibal
North Carolina
Duke University Medical Center
RECRUITING
Durham
Pulmonix, LLC
RECRUITING
Greensboro
East Carolina University
RECRUITING
Greenville
New Hampshire
Dartmouth Hitchcock Medical Center
RECRUITING
Lebanon
New Jersey
Jersey Shore University Medical Center
RECRUITING
Neptune City
Nevada
Renown Regional Medical Center
RECRUITING
Reno
New York
NYU Langone Medical Center
RECRUITING
New York
Montefiore Medical Center
RECRUITING
The Bronx
Oregon
Legacy Health
RECRUITING
Portland
Pennsylvania
St. Luke's University Health Network
RECRUITING
Bethlehem
South Carolina
AnMed Health Pulmonary and Sleep Medicine
RECRUITING
Anderson
Prisma Health
RECRUITING
Columbia
Tennessee
StatCare Pulmonary Consultants
RECRUITING
Knoxville
Texas
Premier Pulmonary Critical Care and Sleep Medicine
RECRUITING
Denison
Houston Methodist Hospital
RECRUITING
Houston
The University of Texas Health Science Center at San Antonio
RECRUITING
San Antonio
Utah
Intermountain Healthcare
RECRUITING
Murray
University of Utah Health
RECRUITING
Salt Lake City
Virginia
University of Virginia
RECRUITING
Charlottesville
Inova Fairfax Hospital
RECRUITING
Falls Church
Sentara Cardiovascular Research Institute
RECRUITING
Norfolk
Pulmonary Associates of Richmond
RECRUITING
Richmond
Vermont
The University of Vermont Medical Center
RECRUITING
Burlington
Washington
Providence Medical Research Center
COMPLETED
Spokane
Wisconsin
Medical College of Wisconsin
RECRUITING
Milwaukee
West Virginia
Marshall Health
RECRUITING
Huntington
Contact Information
Primary
United Therapeutics Global Medical Information
clinicaltrials@unither.com
919-485-8350
Time Frame
Start Date: 2023-08-11
Estimated Completion Date: 2026-02
Participants
Target number of participants: 300
Treatments
Experimental study arm
All enrolled patients in this single arm study will receive a RHC.
Sponsors
Leads: United Therapeutics

This content was sourced from clinicaltrials.gov